Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 9 more sites

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jan 03, 2023 10:12pm

199 Views

Post# 35201965

RE:9 more sites

In communications (MD&A, news releases), TLT had hinted us about "up to 15", despite having 12 now.

Good thing that they plan to add 9 more in 2023, on top of the actual 12 ones as it will give us more visibility and we'll l'ose who is interested in on-boarding. That could be very telling. For example, MD-Anderson (#1 in the US, Dr. Kamat), Dana-Farber (Harvard), UCLA (big market over there), Memorial-Sloan-Kettering (NY), etc ...

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?